Cargando…
Artificially cloaked viral nanovaccine for cancer immunotherapy
Virus-based cancer vaccines are nowadays considered an interesting approach in the field of cancer immunotherapy, despite the observation that the majority of the immune responses they elicit are against the virus and not against the tumor. In contrast, targeting tumor associated antigens is effecti...
Autores principales: | Fusciello, Manlio, Fontana, Flavia, Tähtinen, Siri, Capasso, Cristian, Feola, Sara, Martins, Beatriz, Chiaro, Jacopo, Peltonen, Karita, Ylösmäki, Leena, Ylösmäki, Erkko, Hamdan, Firas, Kari, Otto K., Ndika, Joseph, Alenius, Harri, Urtti, Arto, Hirvonen, Jouni T., Santos, Hélder A., Cerullo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917704/ https://www.ncbi.nlm.nih.gov/pubmed/31848338 http://dx.doi.org/10.1038/s41467-019-13744-8 |
Ejemplares similares
-
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
por: Ylösmäki, Erkko, et al.
Publicado: (2021) -
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy
por: Ylösmäki, Leena, et al.
Publicado: (2019) -
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses
por: Ylösmäki, Erkko, et al.
Publicado: (2018) -
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2021) -
A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
por: Fusciello, Manlio, et al.
Publicado: (2022)